Thursday, July 23, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Senate Banking Committee Approves CLARITY Act, Advancing U.S. Crypto Market Structure Bill

The U.S. Senate Banking Committee approved the CLARITY Act, categorizing virtual assets and addressing stablecoin regulations, but ethics provisions were rejected.

Unstoppable Trump? Crypto Markets Respond Positively to His Safety

The cryptocurrency market is rallying as Republican presidential candidate Donald Trump appears to be in good shape despite being shot.

Tag: disruptive behavior

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.